Gut microbiota of Type 1 diabetes patients with good glycaemic control and high physical fitness is similar to people without diabetes: an observational study

被引:39
作者
Stewart, C. J. [1 ,2 ]
Nelson, A. [1 ]
Campbell, M. D. [1 ,3 ]
Walker, M. [4 ]
Stevenson, E. J. [1 ,4 ]
Shaw, J. A. [4 ]
Cummings, S. P. [1 ]
West, D. J. [1 ,4 ]
机构
[1] Northumbria Univ, Fac Hlth & Life Sci, Newcastle Upon Tyne, Tyne & Wear, England
[2] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[3] Leeds Beckett Univ, Carnegie Res Inst, Leeds, W Yorkshire, England
[4] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England
关键词
DISEASE; BACTERIAL; HUMANS; OBESE; MOUSE;
D O I
10.1111/dme.13140
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimType 1 diabetes is the product of a complex interplay between genetic susceptibility and exposure to environmental factors. Existing bacterial profiling studies focus on people who are most at risk at the time of diagnosis; there are limited data on the gut microbiota of people with long-standing Type 1 diabetes. This study compared the gut microbiota of patients with Type 1 diabetes and good glycaemic control and high levels of physical-fitness with that of matched controls without diabetes. MethodsTen males with Type 1 diabetes and ten matched controls without diabetes were recruited; groups were matched for gender, age, BMI, peak oxygen uptake (VO2max), and exercise habits. Stool samples were analysed using next-generation sequencing of the 16S rRNA gene to obtain bacterial profiles from each individual. Phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) was implemented to predict the functional content of the bacterial operational taxonomic units. ResultsFaecalibacterium sp., Roseburia sp. and Bacteroides sp. were typically the most abundant members of the community in both patients with Type 1 diabetes and controls, and were present in every sample in the cohort. Each bacterial profile was relatively individual and no significant difference was reported between the bacterial profiles or the Shannon diversity indices of Type 1 diabetes compared with controls. The functional profiles were more conserved and the Type 1 diabetes group were comparable with the control group. ConclusionsWe show that both gut microbiota and resulting functional bacterial profiles from patients with long-standing Type 1 diabetes in good glycaemic control and high physical fitness levels are comparable with those of matched people without diabetes. What's new? This study is the first to explore the gut microbiota in patients with Type 1 diabetes, but who otherwise have good glycaemic control and high physical fitness. The gut microbiota from people with Type 1 diabetes and good glycaemic control and high physical fitness was comparable with that from matched healthy controls without diabetes.
引用
收藏
页码:127 / 134
页数:8
相关论文
共 23 条
[1]  
[Anonymous], 2017, DIABET MED, V34, P127
[2]   Effect of Antibiotic Treatment on the Intestinal Metabolome [J].
Antunes, L. Caetano M. ;
Han, Jun ;
Ferreira, Rosana B. R. ;
Lolic, Petra ;
Borchers, Christoph H. ;
Finlay, B. Brett .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (04) :1494-1503
[3]   Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease [J].
Atkinson, M. A. ;
Chervonsky, A. .
DIABETOLOGIA, 2012, 55 (11) :2868-2877
[4]   Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse [J].
Calcinaro, F ;
Dionisi, S ;
Marinaro, M ;
Candeloro, P ;
Bonato, V ;
Marzotti, S ;
Corneli, RB ;
Ferretti, E ;
Gulino, A ;
Grasso, F ;
De Simone, C ;
Di Mario, U ;
Falorni, A ;
Boirivant, M ;
Dotta, F .
DIABETOLOGIA, 2005, 48 (08) :1565-1575
[5]   Metabolic Implications when Employing Heavy Pre- and Post-Exercise Rapid-Acting Insulin Reductions to Prevent Hypoglycaemia in Type 1 Diabetes Patients: A Randomised Clinical Trial [J].
Campbell, Matthew D. ;
Walker, Mark ;
Trenell, Michael I. ;
Luzio, Steven ;
Dunseath, Gareth ;
Tuner, Daniel ;
Bracken, Richard M. ;
Bain, Stephen C. ;
Russell, Mark ;
Stevenson, Emma J. ;
West, Daniel J. .
PLOS ONE, 2014, 9 (05)
[6]   Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease [J].
Conte, M. P. ;
Schippa, S. ;
Zamboni, I. ;
Penta, M. ;
Chiarini, F. ;
Seganti, L. ;
Osborn, J. ;
Falconieri, P. ;
Borrelli, O. ;
Cucchiara, S. .
GUT, 2006, 55 (12) :1760-1767
[7]  
Eriksson L JE, 2006, MULTI MEGAVARIATE 1, P307
[8]   Toward defining the autoimmune microbiome for type 1 diabetes [J].
Giongo, Adriana ;
Gano, Kelsey A. ;
Crabb, David B. ;
Mukherjee, Nabanita ;
Novelo, Luis L. ;
Casella, George ;
Drew, Jennifer C. ;
Ilonen, Jorma ;
Knip, Mikael ;
Hyoty, Heikki ;
Veijola, Riitta ;
Simell, Tuula ;
Simell, Olli ;
Neu, Josef ;
Wasserfall, Clive H. ;
Schatz, Desmond ;
Atkinson, Mark A. ;
Triplett, Eric W. .
ISME JOURNAL, 2011, 5 (01) :82-91
[9]   Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse [J].
Hansen, C. H. F. ;
Krych, L. ;
Nielsen, D. S. ;
Vogensen, F. K. ;
Hansen, L. H. ;
Sorensen, S. J. ;
Buschard, K. ;
Hansen, A. K. .
DIABETOLOGIA, 2012, 55 (08) :2285-2294
[10]  
Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]